A Randomized, Double-Blind, Placebo-Controlled and Active Comparator, 4 Period Crossover Study to Evaluate the Effect of Lemborexant Versus Placebo and Zolpidem on Postural Stability, Auditory Awakening Threshold, and Cognitive Performance in Healthy Subjects 55 Years and Older
Phase of Trial: Phase I
Latest Information Update: 22 Sep 2017
At a glance
- Drugs Lemborexant (Primary) ; Zolpidem (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Eisai Inc
- 19 Sep 2017 Planned End Date changed from 1 Oct 2017 to 1 Jan 2018.
- 19 Sep 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Dec 2017.
- 08 Aug 2017 Planned End Date changed from 1 Jun 2017 to 1 Oct 2017.